Search This Site




Philadelphia Weekly - The Trouble With Spikol


 

 

 

 

Cost of the War in Iraq
(JavaScript Error)

 

 

« We have so much in common. Except that stuff about the pope. | Main | Because ignoring Arkansas just isn't fair »

My sweet Lamictal

suckitzoloft.JPG

Looks like Glaxo is having some trouble getting a patent for its extended release version of Lamictal, an anti-seizure med that I use (off-label?) as a mood stabilizer. From Reuters (belatedly):

NEW YORK, Sept 21 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) said on Friday that U.S. health regulators stopped short of approving a new long-acting version of its widely used epilepsy drug, Lamictal, until certain concerns are addressed.

Europe's largest drugmaker, which received a so-called approvable letter regrading its Lamictal XR, said it is committed to working with the U.S. Food and Drug Administration to address any questions the agency has and to evaluate the best way forward to outright approval.

The company did not specify what FDA questions or concerns must be addressed in order to gain approval.

Lamictal XR is a once daily extended-release formulation of the older medicine, which is taken twice daily by most epilepsy patients. The older version, which had nearly $2 billion in sales last year, is already facing competition from cheap generic versions in Europe and generic competition in the United States could come as soon as next year. (Reporting by Bill Berkrot)

I know Lamictal can have dangerous side effects upon initial treatment; maybe those are intensified with the long-acting version. I've been taking it for years -- knock wood -- with excellent results.

[Image from The Chem Blog]

Comments

“I know Lamictal can have dangerous side effects upon initial treatment; maybe those are intensified with the long-acting version. I've been taking it for years -- knock wood -- with excellent results.” --- Liz Spikol

Now just imagine if those patients who did experience the “dangerous side effects” of this drug and their support people decided to request the banning of this medication. It is similar to groups that want to see ECT banned even though there are other patients who benefit.

Just imagine where you would be if other patients were successful in banning Lamictal from which they had serious side effects.

I can assure you I read similar advocacies for banning numerous medications. Imagine if I had lobbied and successfully campaigned to ban Lamictal because of my spouse’s serious and life threatening side effects from the drug; how happy you’d be now.

The point is I have an understanding that all medications should be properly tested and certified for reasonable safety and efficacy and any patient taking any medication or therapy should be reasonably educated to make informed decisions in collaboration with an attending physician and weigh the benefits against the risks.

From my personal experiences as a support person I’m well aware there is a price to pay whether short-term or down the line from the use of any psychotropic medications. The fact that my spouse encountered serious side effects from Lamictal does not cloud or anger my feelings toward the medication knowing full well that others are more fortunate and are benefiting from the same medication.

What properly have to be addressed are the shortcomings and improprieties on the part of the sponsors of these various therapies to fudge test results and/or promote off label use without proper testing in my opinion.

Warmly
Herb
VNSdepression.com

Herb, I couldn't have said it better myself. We each come from a unique genetic pool, have one-of-a-kind brain chemistry and our life experiences and environment are so personal. A treatment that reeks havoc on one person can be a miracle for another. Like Liz, Lamictal has been a godsend for my daughter. Of course, we need to be cautious about big Pharma and there are some awful and tragic stories out there. Thank you for your balanced viewpoint and for your open-mindedness.

Liz:

Lamictal is now officially FDA-approved for maintenance treatment of bipolar disorder.

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

self portrait web final.JPG

Liz Spikol is senior contributing editor of Philadelphia Weekly. She writes the award-winning column The Trouble With Spikol, which began as a chronicle of her struggle with mental illness, and has since expanded into humorous musings on everything from graphic novels to how to use a mop. She also writes the paper's book review column, Lit Gloss. This blog -- named one of the Top 10 Bipolar Blogs of 2007 by PsychCentral -- is about mental illness policy, news, personal journeys and more.